ATE315561T1 - Carbamatderivate, verfahren zu deren herstellung und deren verwendung - Google Patents

Carbamatderivate, verfahren zu deren herstellung und deren verwendung

Info

Publication number
ATE315561T1
ATE315561T1 AT01982745T AT01982745T ATE315561T1 AT E315561 T1 ATE315561 T1 AT E315561T1 AT 01982745 T AT01982745 T AT 01982745T AT 01982745 T AT01982745 T AT 01982745T AT E315561 T1 ATE315561 T1 AT E315561T1
Authority
AT
Austria
Prior art keywords
optionally substituted
substituted
derivatives
chem
alkyl
Prior art date
Application number
AT01982745T
Other languages
English (en)
Inventor
Fumio Itoh
Hiroshi Banno
Masaki Kawamura
Shuji Kitamura
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of ATE315561T1 publication Critical patent/ATE315561T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01982745T 2000-11-08 2001-11-08 Carbamatderivate, verfahren zu deren herstellung und deren verwendung ATE315561T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000341067 2000-11-08

Publications (1)

Publication Number Publication Date
ATE315561T1 true ATE315561T1 (de) 2006-02-15

Family

ID=18815863

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01982745T ATE315561T1 (de) 2000-11-08 2001-11-08 Carbamatderivate, verfahren zu deren herstellung und deren verwendung

Country Status (7)

Country Link
US (1) US7109200B2 (de)
EP (1) EP1340753B1 (de)
AT (1) ATE315561T1 (de)
AU (1) AU2002214266A1 (de)
CA (1) CA2428123A1 (de)
DE (1) DE60116655T2 (de)
WO (1) WO2002038560A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080221063A1 (en) * 2005-07-08 2008-09-11 Astrazeneca Ab Heterocyclic Sulfonamide Derivatives As Inhibitors Of Factor Xa
US20080200431A1 (en) * 2005-07-08 2008-08-21 Astrazeneca Ab Heterocyclic Sulfonamide Derivatives as Inhibitors of Factor Xa

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612353A (en) * 1995-06-07 1997-03-18 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
WO1999033805A1 (en) * 1997-12-26 1999-07-08 Mochida Pharmaceutical Co., Ltd. Aromatic compounds having cyclic amino or salts thereof
WO1999037304A1 (en) 1998-01-27 1999-07-29 Aventis Pharmaceuticals Products Inc. SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
CA2317017A1 (en) * 1998-02-05 1999-08-12 Takeda Chemical Industries, Ltd. Sulfonamide derivatives, their production and use
FR2781062B1 (fr) * 1998-07-09 2002-07-12 Saint Gobain Vitrage Vitrage a proprietes optiques et/ou energetiques electrocommandables
EP1188755B1 (de) * 1999-06-22 2006-05-03 Takeda Pharmaceutical Company Limited Acylhydrazinderivate, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
CA2428123A1 (en) 2002-05-16
EP1340753A1 (de) 2003-09-03
DE60116655T2 (de) 2006-11-16
EP1340753B1 (de) 2006-01-11
US7109200B2 (en) 2006-09-19
EP1340753A4 (de) 2004-01-14
AU2002214266A1 (en) 2002-05-21
DE60116655D1 (de) 2006-04-06
WO2002038560A1 (en) 2002-05-16
US20040038986A1 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
ATE368655T1 (de) Stickstoffhaltige heterocyclische verbindung und arzneimittel davon
DE69923300D1 (de) Cycloalken-derivate, verfahren zu ihrer herstellung und ihre verwendung
DE60318583D1 (de) N-äphenyl(piperidin-2-yl)methylübenzamid-derivate, verfahren zu deren herstellung und ihre therapeutische verwendung
DE50011034D1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE337805T1 (de) Medizinische materialien und verfahren zu deren herstellung
ATE290524T1 (de) Aromatische aminderivate, verfahren zu ihrer herstellung und mittel, die diese enthalten
AT389108B (de) Neue pyridazinonderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
ATE137500T1 (de) Substituierte pyridinsulfonamidverbindungen, diese enthaltende herbizide zusammensetzungen und verfahren zu ihrer herstellung
MXPA01013148A (es) Nuevos derivados de amonio cuaternario, metodo para la preparacion de los mismos y uso farmaceutico.
EP1219605A4 (de) Harnstoff-verbindungen, ein verfahren zu deren herstellung und ihre verwendung
ATE315561T1 (de) Carbamatderivate, verfahren zu deren herstellung und deren verwendung
ATE302199T1 (de) Quinalozinon-derivate
ATE309198T1 (de) Fungizide mit einer fluorovinyl-oder fluoropropenyloxyphenyloxim-einheit und ein verfahren zu ihrer herstellung.
ATE279191T1 (de) Trizyklische dihydrobenzofurane, verfahren zu deren herstellung und mittel
ATE116304T1 (de) Imidazol-derivate, verfahren zu deren herstellung und diese enthaltende zusammenstellungen.
ATE365162T1 (de) Tetrahydropyridyl-alkyl-heterozykle, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten
ATE261441T1 (de) Analoga von distamycin-zimtsäurederivaten, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
DE69839056D1 (de) Stereoisomere indolderivate, verfahren zu ihrer herstellung und ihre verwendung
DE69837628D1 (de) Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
BR9812928A (pt) Novos derivados de 3-oxo-(2h) -1,2,4-triazina, processo de preparação de compostos quìmicos, e, composição farmacêutica
DE60009893D1 (de) Benzoxazol-derivate, verfahren zu ihrer herstellung und herbizide
DK1433480T3 (da) Lægemiddel indeholdende pyrimidin-derivat
DE602004021411D1 (de) Peptidomimetische verbindungen, stereoselektives verfahren zu deren herstellung und deren verwendung
ATE180251T1 (de) Indan derivate und verfahren zu deren herstellung
ATE22683T1 (de) Substituiertes heterocyclylphenylsulphonyl und phosphonylamidine, verfahren zu deren herstellung und deren pharmazeutische anwendung.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties